DRKS00014672招募中未知
The role of IL-26 in innate and adaptive Immunity of Spondyloarthritis
Abteilung für Nephrologie, Klinikum rechts der Isar der TU München0 个研究点目标入组 170 人开始时间: 2018年5月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Diagnosis of ankylosing spondylitis (modified New York criteria) or of psoriatric arthritis (CASPAR criteria) or of rheumatoid arthritis (EULAR/ACR criteria)
- •Age > 18 years
- •active disease
- •no biologics (anti-TNF, anti-CD20)
- •stable therapy regimen at recruitment
排除标准
- •Failure of inclusion criteria
- •active infections or malignancy
- •other autoimmune disease
- •surgery less than 2 weeks prior to study inclusion
- •patient not capable of consent; no consent
研究者
相似试验
终止
不适用
IL-26 and Systemic Lupus ErythematosusDiagnosis of Lupus According to ACR criteriaAgreement for the Blood SamplingNCT01889641University Hospital, Strasbourg, France23
尚未招募
不适用
Serum IL 26 as a Marker of Disease Activity in SLESLENCT05161988Assiut University52
已完成
不适用
The role and modulation of the adaptive immune response in human limb ischaemia reperfusion injury by ischaemic preconditioningISRCTN66931248ational University of Ireland Galway (Ireland)25
招募中
不适用
Study of the Effect of Innate on the Inflammatory Response to EndotoxinMetabolic SyndromeAtherosclerosisCancerAsthmaInsulin ResistanceNCT01143480National Institute of Environmental Health Sciences (NIEHS)725
已完成
不适用
The possibility of IL-36 cytokines as a novel biomarker of the severity and mortality in the patients with bacteremia or sepsis.Bacteremia and SepsisJPRN-UMIN000033513Tohoku University100